Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter - PubMed (original) (raw)
. 2012 Oct;19(10):1018-29.
doi: 10.1038/gt.2011.167. Epub 2011 Nov 10.
Affiliations
- PMID: 22071971
- DOI: 10.1038/gt.2011.167
Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter
C Brendel et al. Gene Ther. 2012 Oct.
Abstract
Protection against epigenetic silencing is a desirable feature of future gene therapy vectors, in particular for those applications in which transgene expression will not confer growth advantage to gene-transduced cells. The ubiquitous chromatin opening element (UCOE) consisting of the methylation-free CpG island encompassing the dual divergently transcribed promoters of the human HNRPA2B1-CBX3 housekeeping genes (A2UCOE) has been shown to shield constitutive active heterologous promoters from epigenetic modifications and chromosomal position effects. However, it is unclear if this element can be used to improve expression from tissue-specific enhancer/promoters, while maintaining tissue specificity in hematopoietic cells. Here, we evaluated the potential of the A2UCOE in combination with the myeloid-specific myeloid related protein 8 (MRP8) promoter to target transgene expression specifically to myeloid cells in vitro and in vivo from a self-inactivating lentiviral vector. The inclusion of the A2UCOE did not interfere with specific upregulation of MRP8 promoter activity during myeloid differentiation and mediated sustained and vector copy-dependent expression in myeloid cells. Notably, the A2UCOE did not protect the MRP8 promoter from methylation in the P19 embryonal carcinoma cell line, suggesting that this element maintains the inherent epigenetic state and transcriptional activity of cellular promoters in their native configuration. Thus, the A2UCOE could represent a useful protective genetic element in gene therapy vectors, ensuring physiological transcriptional regulation of tissue-specific promoters independent of the chromosomal integration site.
Similar articles
- Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.
Zhang F, Thornhill SI, Howe SJ, Ulaganathan M, Schambach A, Sinclair J, Kinnon C, Gaspar HB, Antoniou M, Thrasher AJ. Zhang F, et al. Blood. 2007 Sep 1;110(5):1448-57. doi: 10.1182/blood-2006-12-060814. Epub 2007 Apr 24. Blood. 2007. PMID: 17456723 Free PMC article. - A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.
Zhang F, Frost AR, Blundell MP, Bales O, Antoniou MN, Thrasher AJ. Zhang F, et al. Mol Ther. 2010 Sep;18(9):1640-9. doi: 10.1038/mt.2010.132. Epub 2010 Jun 29. Mol Ther. 2010. PMID: 20588258 Free PMC article. - A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells.
Müller-Kuller U, Ackermann M, Kolodziej S, Brendel C, Fritsch J, Lachmann N, Kunkel H, Lausen J, Schambach A, Moritz T, Grez M. Müller-Kuller U, et al. Nucleic Acids Res. 2015 Feb 18;43(3):1577-92. doi: 10.1093/nar/gkv019. Epub 2015 Jan 20. Nucleic Acids Res. 2015. PMID: 25605798 Free PMC article. - Ubiquitous Chromatin-opening Elements (UCOEs): Applications in biomanufacturing and gene therapy.
Neville JJ, Orlando J, Mann K, McCloskey B, Antoniou MN. Neville JJ, et al. Biotechnol Adv. 2017 Sep;35(5):557-564. doi: 10.1016/j.biotechadv.2017.05.004. Epub 2017 May 17. Biotechnol Adv. 2017. PMID: 28528197 Review. - Optimizing retroviral gene expression for effective therapies.
Antoniou MN, Skipper KA, Anakok O. Antoniou MN, et al. Hum Gene Ther. 2013 Apr;24(4):363-74. doi: 10.1089/hum.2013.062. Hum Gene Ther. 2013. PMID: 23517535 Review.
Cited by
- The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells.
Sharma N, Hollensen AK, Bak RO, Staunstrup NH, Schrøder LD, Mikkelsen JG. Sharma N, et al. PLoS One. 2012;7(10):e48421. doi: 10.1371/journal.pone.0048421. Epub 2012 Oct 26. PLoS One. 2012. PMID: 23110238 Free PMC article. - Differential Transgene Silencing of Myeloid-Specific Promoters in the AAVS1 Safe Harbor Locus of Induced Pluripotent Stem Cell-Derived Myeloid Cells.
Klatt D, Cheng E, Hoffmann D, Santilli G, Thrasher AJ, Brendel C, Schambach A. Klatt D, et al. Hum Gene Ther. 2020 Feb;31(3-4):199-210. doi: 10.1089/hum.2019.194. Epub 2020 Jan 23. Hum Gene Ther. 2020. PMID: 31773990 Free PMC article. - Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.
Brendel C, Hänseler W, Wohlgensinger V, Bianchi M, Tokmak S, Chen-Wichmann L, Kuzmenko E, Cesarovic N, Nicholls F, Reichenbach J, Seger R, Grez M, Siler U. Brendel C, et al. Hum Gene Ther Methods. 2013 Jun;24(3):151-9. doi: 10.1089/hgtb.2012.157. Epub 2013 May 2. Hum Gene Ther Methods. 2013. PMID: 23489116 Free PMC article. - Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expression.
Wong RL, Sackey S, Brown D, Senadheera S, Masiuk K, Quintos JP, Colindres N, Riggan L, Morgan RA, Malech HL, Hollis RP, Kohn DB. Wong RL, et al. Blood. 2023 Mar 2;141(9):1007-1022. doi: 10.1182/blood.2022016074. Blood. 2023. PMID: 36332160 Free PMC article. - The effect of different collagen modifications for titanium and titanium nitrite surfaces on functions of gingival fibroblasts.
Ritz U, Nusselt T, Sewing A, Ziebart T, Kaufmann K, Baranowski A, Rommens PM, Hofmann A. Ritz U, et al. Clin Oral Investig. 2017 Jan;21(1):255-265. doi: 10.1007/s00784-016-1784-5. Epub 2016 Mar 12. Clin Oral Investig. 2017. PMID: 26969500
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous